Hims & Hers Health, Inc. (HIMS) Tops Q2 EPS by 5c, Revenue Guidance Beats

August 11, 2021 4:28 PM EDT
Get Alerts HIMS Hot Sheet
Price: $3.97 +7.30%

Today's EPS Names:
CGC, SAFM, NTZ, More
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Hims & Hers Health, Inc. (NYSE: HIMS) reported Q2 EPS of ($0.05), $0.05 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $60.7 million versus the consensus estimate of $56.49 million.

GUIDANCE:

Hims & Hers Health, Inc. sees FY2021 revenue of $251-255 million, versus the consensus of $226.3 million.

  • Adjusted EBITDA to be in the range of $(35) million to $(40) million.

Hims & Hers Health, Inc. sees Q3 2021 revenue of $69-71 million, versus the consensus of $58.3 million.

  • Adjusted EBITDA to be in the range of $(9) million to $(11) million.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings